Rani Therapeutics
NASDAQ: RANISan Jose, US · Founded 2012 · California LLC · 3 known investors
Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles. The company targets patients with chronic conditions who currently require painful injections.
Founders & leadership
MH
Board
MI
AF
Andrew FarquharsonBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$111.8M disclosed across 4 rounds · 2015–2020
▶$50MraisedNov 2020 · 2 investors · BiotechnologyRule 506(b)
▶$50MraisedNov 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Svai SanfordExecutive Officer
- Maulik NanavatyDirector
- Andrew FarquharsonDirector
- Mir HashimExecutive Officer, Director
- Mir ImranExecutive Officer, Director
- Dennis AusielloDirector
- Offering amount
- $75M
- Amount sold
- $50M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Limited Liability Company, California
- Federal exemptions
- 06b
▶$38.7MraisedSep 2017 · 12 investors · Other Health CareRule 506(b)
▶$38.7MraisedSep 2017 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir ImranExecutive Officer, Director
- David PyottDirector
- Mir HashimExecutive Officer, Director
- Andrew FarquharsonDirector
- Maulik NanavatyDirector
- Offering amount
- $126.5M
- Amount sold
- $38.7M
- Minimum investment
- $1
- Sales commissions
- $172K
- Placement agents
- Joseph Gunnar & Co. LLC
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
▶$15.5MraisedJun 2015 · 10 investors · Other Health CareRule 506(b)
▶$15.5MraisedJun 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir HashimExecutive Officer, Director
- Mir ImranExecutive Officer, Director
- Andrew FarquharsonDirector
- Offering amount
- $52.3M
- Amount sold
- $15.5M
- Minimum investment
- $1
- First sale
- May 2015
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
▶$7.7MraisedJun 2015 · 2 investors · Other Health CareRule 506(b)
▶$7.7MraisedJun 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mir ImranExecutive Officer, Director
- Mir HashimExecutive Officer, Director
- Andrew FarquharsonDirector
- Offering amount
- $15M
- Amount sold
- $7.7M
- Minimum investment
- $1
- Sales commissions
- $320K
- Placement agents
- Joseph Gunnar & Co. LLC
- First sale
- May 2015
- Incorporated
- Limited Liability Company, California, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Robinhood29 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha29 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Public28 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingView27 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Simply Wall St26 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
StockTwits25 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TipRanks24 shared keywordsFinancial analysis and stock research platform.
Companies competing with Rani Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Rani Therapeutics do?
- Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles. The company targets patients with chronic conditions who currently require painful injections.
- Who are Rani Therapeutics's investors?
- Rani Therapeutics's investors include InCube Ventures, RA Capital, VHM.
- How much funding has Rani Therapeutics raised?
- Rani Therapeutics has disclosed $111.8M raised across 4 rounds.
- Where is Rani Therapeutics headquartered?
- Rani Therapeutics is headquartered in San Jose, US.